These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 3279631)
21. A high plasma prostaglandin to thromboxane ratio protects against renal ischemia. Kaufman RP; Anner H; Kobzik L; Valeri CR; Shepro D; Hechtman HB Surg Gynecol Obstet; 1987 Nov; 165(5):404-9. PubMed ID: 3672299 [TBL] [Abstract][Full Text] [Related]
22. Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma. Takami M; Takata Y; Matsumoto K; Ono S; Tsukada W Ann N Y Acad Sci; 1991; 629():407-9. PubMed ID: 1952565 [No Abstract] [Full Text] [Related]
28. Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor. Smeesters C; Chaland P; Giroux L; Moutquin JM; Etienne P; Douglas F; Corman J; St-Louis G; Daloze P Transplant Proc; 1988 Apr; 20(2 Suppl 2):663-9. PubMed ID: 3163209 [No Abstract] [Full Text] [Related]
29. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome. Zipser RD; Kronborg I; Rector W; Reynolds T; Daskalopoulos G Gastroenterology; 1984 Dec; 87(6):1228-32. PubMed ID: 6593268 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist. Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268 [TBL] [Abstract][Full Text] [Related]
31. Lack of protective effect of thromboxane synthetase inhibitor (CGS-13080) on single dose radiated canine intestine. Barter JF; Marlow D; Kamath RK; Harbert J; Torrisi JR; Barnes WA; Potkul RK; Newsome JT; Delgado G Gynecol Oncol; 1991 Mar; 40(3):218-21. PubMed ID: 2013442 [TBL] [Abstract][Full Text] [Related]
32. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses. Hardee MM; Moore JN; Hardee GE Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992 [TBL] [Abstract][Full Text] [Related]
33. A comparison of human pulmonary arterial and venous prostacyclin and thromboxane synthesis--effect of a thromboxane synthase inhibitor. Carter AJ; Bevan JA; Hanley SP; Morgan WE; Turner DR Thromb Haemost; 1984 Apr; 51(2):257-60. PubMed ID: 6377567 [TBL] [Abstract][Full Text] [Related]
34. 1986: Pharmacological, hematological, and physiological effects of a new thromboxane synthetase inhibitor (CGS-13080) during cardiopulmonary bypass in dogs. Updated in 1994. DeAnda A; Miller DC Ann Thorac Surg; 1994 Mar; 57(3):778-80. PubMed ID: 7511885 [No Abstract] [Full Text] [Related]
35. Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion. O'Connor KM; Friehling TD; Kelliher GJ; MacNab MW; Wetstein L; Kowey PR Am Heart J; 1986 Apr; 111(4):683-8. PubMed ID: 3953390 [TBL] [Abstract][Full Text] [Related]
36. Prolongation of platelet survival in hypercholesterolaemic rabbits by CGS 12970 (3-methyl-2-(3-pyridyl)-1 indoleoctanoic acid) and dazoxiben. Butler KD; Butler PA; Shand RA; Ambler J; Wallis RB Thromb Res; 1987 Mar; 45(6):751-61. PubMed ID: 3109067 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of thromboxane biosynthesis by 3-pyridinol carboxypentyl ethers substituted with a hydroxylated octyl chain. Conti S; Desideri N; Passaghe S; Castagnoli MN; Cerletti C; Stein ML J Pharm Pharmacol; 1988 Feb; 40(2):144-6. PubMed ID: 2897452 [TBL] [Abstract][Full Text] [Related]
38. Urine thromboxane as an immunologic monitor in kidney transplant patients. Foegh ML; Alijani M; Helfrich GB; Schreiner GE; Ramwell PW Transplant Proc; 1984 Dec; 16(6):1603-5. PubMed ID: 6390872 [No Abstract] [Full Text] [Related]
39. Determination of the effects of inhibition of pulmonary thromboxane A2 synthase activity, in vivo and in vitro. McNamara DB; Kerstein MD; Harrington JK; Bellan JA; Graybar GB; Hyman AL; Kadowitz PJ Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():531-4. PubMed ID: 2526532 [No Abstract] [Full Text] [Related]
40. Application of prostacyclin analogue and thromboxane synthetase inhibitor to chronic vascular rejection after kidney transplantation. Teraoka S; Takahashi K; Toma H; Sanaka T; Yamaguchi Y; Tanabe K; Sato H; Kawaguchi H; Oba S; Nakajima I Transplant Proc; 1987 Oct; 19(5):3664-8. PubMed ID: 3313883 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]